A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/59985/MonH-2020-203065(v1)
NMA SSA Reference Number: SSA/59985/MonH-2020-218315(v2)
Monash Health Reference: RES-20-0000-126A
Effective start/end date7/07/206/07/25


  • clinical trial
  • treatment safety
  • treatment efficacy
  • cardiovascular disease